Genenta Science S.p.A. (ADR)
General ticker "GNTA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $69.5M (TTM average)
Genenta Science S.p.A. (ADR) does not follow the US Stock Market performance with the rate: -36.3%.
Estimated limits based on current volatility of 4.4%: low 0.67$, high 0.73$
Factors to consider:
- Total employees count: 7 as of 2021
Short-term GNTA quotes
Long-term GNTA plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €0.00MM | €0.00MM | €0.00MM |
| Operating Expenses | €11.53MM | €10.20MM | €6.34MM |
| Operating Income | €-11.53MM | €-10.20MM | €-6.34MM |
| Non-Operating Income | €0.09MM | €0.89MM | €0.07MM |
| Interest Expense | €0.00MM | €0.00MM | €0.38MM |
| R&D Expense | €6.36MM | €5.03MM | €2.59MM |
| Income(Loss) | €-11.44MM | €-9.31MM | €-6.27MM |
| Profit(Loss)* | €-11.24MM | €-9.71MM | €-6.01MM |
| Stockholders Equity | €20.43MM | €12.50MM | €21.84MM |
| Assets | €22.35MM | €14.82MM | €31.89MM |
| Operating Cash Flow | €-11.21MM | €-6.24MM | €-6.87MM |
| Capital expenditure | €0.01MM | €0.00MM | €0.01MM |
| Investing Cash Flow | €-14.89MM | €6.88MM | €-14.54MM |
| Financing Cash Flow | €0.00MM | €0.27MM | €22.29MM |
| Earnings Per Share** | €-0.62 | €-0.53 | €-0.31 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.